Measuring Relative Wind Speeds in Stratospheric Balloons with Cup Anemometers: The TASEC-Lab Mission.

This paper shows wind speed measurements from the TASEC-Lab experiment in a stratospheric balloon mission. The mission was launched in July 2021 from León (Spain) aerodrome. Measurements of horizontal wind speed in relation to the balloon gondola were successfully carried out with a cup anemometer.

Genetic Algorithm Approach to the 3D Node Localization in TDOA Systems.

Positioning asynchronous architectures based on time measurements are reaching growing importance in Local Positioning Systems (LPS). These architectures have special relevance in precision applications and indoor/outdoor navigation of automatic vehicles such as Automatic Ground Vehicles (AGVs) and Unmanned Aerial Vehicles (UAVs). The positioning error of these systems is conditioned by the algorithms used in the position calculation, the quality of the time measurements, and the sensor deployment of the signal receivers.

[Clinical practice guideline for the diagnosis and treatment of hyperprolactinemia].

Background: Hyperprolactinemia is a common finding within clinical practice in both endocrinology and general practice fields, amongst other specialties. The general practitioner and other specialists must know the indications and serum prolactin determination parameters in order to, once detected, derive the patient for a correct assessment and begin treatment.

Objective: Formulate a clinical practice guideline evidence-based for the diagnosis and treatment of hyperprolactinemia.

[Autoantibodies in GAD65 in Mexican adults with diabetes types 1 and 2 and their siblings].

Background: Pancreatic cell destruction causing type 1 diabetes is associated to diverse autoantibodies. Antibodies against glutamic acid decarboxylase have been found in type 1 (DM1) and type 2 diabetic patients (DM2). Their presence in siblings is unknown.

[Usefulness of cabergoline in patients with prolactinemia and resistant or intolerant to bromocriptine].

Background: Dopaminergic agonists are the treatment of choice for prolactinomas with bromocriptine (BCE) being the primary agent used. There is a group of patients who are not responders to such therapy or have severe side effects (resistant or intolerant to BCE, respectively). We undertook this study to evaluate the response to the administration of cabergoline (CBG) in patients intolerant or resistant to BCE.

Neuro-otologic symptoms in patients with type 2 diabetes mellitus.

To assess the prevalence of balance symptoms in type-2 diabetes mellitus (DM2), at the first level of health care. Compared to 101 controls, 101 patients showed a higher frequency of all the symptoms investigated through a standardized questionnaire (p<0.01).

Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study.

Objective: Cabergoline is a dopamine agonist used to treat hyperprolactinaemia. Because hyperprolactinaemia is a significant cause of infertility in women, cabergoline and other dopamine agonists are frequently prescribed to reduce prolactin levels and restore normal menses. They are usually discontinued shortly after the patient becomes pregnant.

[History of clinical studies on hypothalamic hormone analogs in Mexico].

Early clinical trials in Mexico with analogs of luteinizing hormone-releasing hormone (LH-RH) also known as gonadotropin releasing hormone (Gn-RH), were reviewed. Extensive clinical studies were carried out at IMSS with agonists of LH-RH, both in men and woman. All subjects responded to LH-RH agonists with a release of LH and FSH, but repeated administration of these analogs, initially aimed at stimulation of fertility (thought to stimulate fertility), was later shown to result in inhibition due to desensitization of pituitary gland and downregulation of LH-RH receptors.

[Hypertriglyceridemic pancreatitis during pregnancy. A report of a case].

Acute pancreatitis during pregnancy is an uncommon complication. The usual cause is biliary tract disease. Cholesterol and triglyceride plasma levels physiologically increase during pregnancy.

Response of patients with advanced prostatic cancer to administration of somatostatin analog RC-160 (vapreotide) at the time of relapse.

Background: The aim of this study was to evaluate the effects of administration of the somatostatin analog RC-160 (vapreotide) at the time of relapse in patients with androgen independent prostate cancer.

Methods: Our study included 13 patients with biopsy-proven prostate cancer, stage D3. Eight patients had been treated with a depot formulation of the agonist D-Trp-6-LH-RH, with a median remission time of 68 (range 48-102 months).

[Response of gastrin after an oral calcium load in healthy women and in postmenopausal patients without hormone replacement therapy].

Background: Gastrin has a wide variety of functions on the digestive system including the regulation of gastric acid secretion, being a growth factor for the non antral gastric mucosa and the stimulation of mucosal proliferation in the large and small intestines. Animals studies showed that various diseases of the digestive system have better clinical evolution in the presence of estrogens as is the case of peptic ulcers, now little is known in humans about this phenomenon.

Objective: To evaluate the response of gastrin after an oral calcium load in normal and postmenopausal women without hormone replacement therapy.